Asahi Glass Company, Limited

Oryza Oil & Fat Chemical Co., Ltd.

Gm Global Technolgoy Operations, Inc.

Panasonic Intellectual Property Management Co., Ltd.

Matsushita Electric Industrial Co., Ltd.

Mitsubishi Denki Kabushiki Kaisha

Panasonic Corporation

Nec Electronics Corporation

Saint-gobain Vitrage

Keio University

Saint-gobain Vitrage International

Hiroshi Shimoda

Shinji Kinoshita

Hiromichi Murai

Hirokazu Wakabayashi

Seigo Kotera

Makoto Hasegawa

Hiroshi Kumai

Toshihiro Tanuma

Kenta Sekikawa

Satoshi Kashiwabara

Hiroyuki Arishima

Atsushi Mukoyama

Junji Tanaka

Satoru Hommura

Takashi Shibuya

Chunxin Ji

Hubert Gasteiger

Hideki Nakagawa

Shinji Terazono

Susan Yan

Bhaskar Sompalli

Noriyuki Yoshihara

Mitsuo Osawa

Tadashi Okada

Fumiaki Oobayashi

Kohta Yamada

Katsushi Kamijyo

Hirotake Ishii

Shigeru Nakamura

Kazuhito Hatoh

Makoto Uchida

Teruhisa Kanbara

Hisaaki Gyoten

Hiroshi Kurokawa

Tetsuji Shimohira

Junji Niikura

Hiroki Hotaka

Kazuhiko Shiono

Hiroyuki Watanabe

Jean-Louis M Bravet

Yasuo Takebe

Yuriko Kaida

Yoshiaki Higuchi

Susumu Saito

Masato Hosaka

Kazuo Tsubota

Ichiro Terada

Michel J Moncheaux

Kosuke Uchiyama

Teppei Konishi

Mikio Iwakawa

Atsushi Komori

Michio Aitani

Widjaja Hardiyanto

Yoshiyuki Kuwabara

Kimi Ueda

Kaori Yoshida

Shota Shimonaka

Toshihiro Okajima

Takashi Watanabe

Kenchi Miyasaka

Norihito Shimizu

Toru Takarada

Shaojie Shan

Atsuo Okawara

Emi Yamada

Tomoko Sugishita

Masayuki Yoshikawa

Aya Ikoma

Kyoichi Seo

Shutaro Kunimasa

Kotaro Oishi

Kazune Miyagi

Takashi Kadekaru

Toshihiro Imada

A 5α-reductase inhibitor contains saw palmetto extract and seaberry extract as an active ingredient in a synergistic compounding ratio, wherein the compounding ratio by weight of the saw palmetto extract and the seaberry extract is 3:1˜2. The 5α-reductase inhibitor containing the saw palmetto extract and seaberry extract or just the seaberry extract as a 5α-reductase inhibitor can be administered to the human body in order to inhibit 5α-reductase. The 5α-reductase inhibitor is useful as a prostate enlargement inhibitor, an androgenic alopecia inhibitor, and an acne prevention and amelioration agent. The 5α-reductase inhibitor can be part of a food or drink composition or a cosmetic composition.

Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity

A method of reducing muscle damage in a human being includes providing an extract of Kenyan purple tea (scientific name:; variety name: TRFK306) containing 1,2-di-O-galloyl-4,6-O—(S)-hexahydroxydiphenoyl-β-D-glucose (GHG). Then, an effective amount of the purple tea extract is administered to a body of a human being engaged in intensive exercise to reduce muscle damage associated with the intensive exercise.

Method of reducing muscle damage associated with intensive exercise by administering purple-tea extract

An intellectual productivity evaluation device includes: an obtainment unit configured to obtain a set of answer times required by a subject to accomplish a task of answering a plurality of questions, the task being imposed on the subject as intellectual work; an evaluation unit configured to calculate an evaluation value related to a depth of concentration of the subject in a concentrated state using the set of answer times obtained by the obtainment unit based on a model in which the subject is in the concentrated state or an unconcentrated state during the intellectual work; and an output unit configured to output evaluation value information indicating the evaluation value calculated by the evaluation unit.

Intellectual productivity evaluation device and intellectual productivity evaluation method

An AMP-activated protein kinase (AMPK) activating agent comprises 1,2-di-O-galloyl-4,6-O&#x2014;(S)-hexahydroxydiphenoyl-b-D-glucose ('GHG') as an active ingredient. The AMPK activating agent can be a GHG-containing composition wherein the GHG is an active ingredient of the composition. The GHG-containing composition can be derived from Kenyan purple tea, whose scientific name is, variety name: TRFK306. An effective amount of the GHG can be administered to a cell to activate the AMPK. Drinks, foods, and cosmetics can have the GHG as an active ingredient.

AMPK activating agent

This invention provides a prophylactic and therapeutic agent for dry eye, having new ingredients to reduce the deterioration of the lacrimal secretory ability and to inhibit the generation of radical oxygen in lacrimal gland tissue. The prophylactic and therapeutic agent for dry eye of this invention contains the maqui berry extract as the active substance of this invention, i.e. containing delphinidin glycoside extracted from the maqui berry and at least one or more of the active substances delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, preferably delphinidin-3,5-diglucoside.

Method of improving lacrimal secretion for dry eye treatment using maqui berry extract

An intellectual-productivity analysis apparatus includes a presentation device, an input device, and an evaluation device. The presentation device presents a plurality of questions to a test subject. The input device allows the test subject input an answer to each question. The evaluation device includes a work memory part and an evaluating arithmetic part. The work memory part stores the answering time from a time when a question is presented on the presentation device to a time when the answer is inputted into the input device for each of the plurality of questions. The evaluating arithmetic part calculates an evaluation value on the intellectual productivity of the test subject during a measurement period of measuring the answering time of each of the plurality of questions by extracting a feature amount from the set of the answering time stored in the work memory part.

Intellectual-productivity analysis apparatus and program

To provide a manufacturing method of a composite film for laminated glass, the method enabling the high-yield manufacture of the composite film that causes less appearance failure in the obtained laminated glass, while ensuring smooth workability. A manufacturing method of a composite film composed of a resin intermediate film and a plastic film for laminated glass, including: feeding the resin intermediate film with 0.04 to 0.4 N/cm tension and the plastic film, between a two rolls whose surface temperatures are 25 to 50&#xb0; C., and pressing these to obtain a laminate; and feeding the laminate between a third roll whose surface temperature is 60&#xb0; C. or higher and lower than Tg of a resin in the plastic film and a fourth roll whose surface temperature is lower than this by 15 to 30&#xb0; C., so as to bring the plastic film into contact with the third roll, and pressing the laminate.

Manufacturing method of composite film

The present invention relates to an optical filter, a solid-state imaging element and an imaging device lens which contain a near infrared ray absorbing layer having a specific near infrared ray absorbing dye dispersed in a transparent resin having a refractive index of 1.54 or more, and also relates to an imaging device containing the solid-state imaging element or the imaging device lens. The near infrared ray absorbing layer has a transmittance of visible light of from 450 to 600 nm of 70% or more, a transmittance of light in a wavelength region of from 695 to 720 nm of not more than 10%, and an amount of change of transmittance of not more than &#x2212;0.8.

Optical filter, solid-state imaging element, imaging device lens and imaging device

An optical filter including a near infrared absorbing layer on a glass substrate, in which adhesiveness between the glass substrate and the near infrared absorbing layer is firm, high reliability is enabled in uses under a high temperature and high humidity environment, and manufacturing yield is secured, and a high reliability solid-state imaging device having the optical filter are provided. An optical filter includes: a glass substrate; and a near infrared absorbing layer formed on one principal surface of the glass substrate, wherein the near infrared absorbing layer is obtained by reacting a composition for forming the near infrared absorbing layer on the glass substrate and the composition contains a transparent resin having a fluorene skeleton and a reactivity group; a near infrared absorbing dye; and a silane coupling agent and/or oligomer thereof having a hydrolyzable group and a functional group which have reactivity for the reactivity group.

Optical filter and solid-state imaging device

There are provided a near-infrared cut filter that effectively uses near-infrared absorbing glass and a near-infrared absorbing dye and is excellent in a near-infrared shielding property, and a high-sensitivity solid-state imaging device including the same. A near-infrared cut filter includes: a near-infrared absorbing glass substrate made of CuO-containing fluorophosphate glass or CuO-containing phosphate glass; and a near-infrared absorbing layer containing a near-infrared absorbing dye (A) and a transparent resin (B), on at least one principal surface of the near-infrared absorbing glass substrate, wherein an average value of a transmittance in a 400 nm to 550 nm wavelength range is 80% or more, and an average value of a transmittance in a 650 nm to 720 nm wavelength range is 15% or less.

Near-infrared cut filter and solid-state imaging device

Disclosed is an AGE production inhibitor or the like, which effectively inhibits the production of an advanced glycation end product (AGE), while having improved biological safety. Specifically disclosed is an AGE production inhibitor or the like, which contains en extract of cherry tree (preferably blossoms or leaves thereof) and/or a processed product of the extract as an active substance. The AGE production inhibitor or the like contains, as an active substance, at least one compound that is selected from among 1-O-(E)-Caffeoyl-&#x3b2;-D-glucopyranoside, 1-O-(E)-Coumaroyl-&#x3b2;-D-glucopyranoside, 1-O-(E)-Cinnamoyl-&#x3b2;-D-glucopyranoside, Kaempferol 3-O-&#x3b2;-D-glucopyranoside, Quercetin 3-O-&#x3b2;-D-glucopyranoside, Kaempferol 3-O-(6&#x2033;-malony)-&#x3b2;-D-glucopyranoside, and Quercetin 3-O-(6&#x2033;-malony)-&#x3b2;-D-glucopyranoside.

Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract

A process is provided whereby a membrane/electrode assembly for polymer electrolyte fuel cells whereby a high output voltage is obtainable within a wide range of current densities. A process for producing a membrane/electrode assemblycomprising a first electrodehaving a first catalyst layerand a first gas diffusion layer, a second electrodehaving a second catalyst layerand a second gas diffusion layer, and an electrolyte membrane, wherein the first gas diffusion layer, a first intermediate having the first catalyst layerformed on the surface of the electrolyte membraneby coating followed by annealing, and a second intermediate having the second catalyst layerformed on the surface of the second gas diffusion layerby coating, are bonded, so that the first catalyst layeris located between the first gas diffusion layerand the electrolyte membrane, and the second catalyst layeris located between the second gas diffusion layerand the electrolyte membrane

Process for producing membrane/ electrode assembly for polymer electrolyte fuel cells

(PROBLEMS) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes. (MEANS FOR SOLVING PROBLEMS) A dietetic composition characterized by comprising, as the active ingredient, a polar solvent extract of defatted green coffee beans. It is preferable that the above-described polar solvent extract is an extract obtained by using water-containing ethanol, still preferably water-containing ethanol having an ethanol concentration of from 40 to 90% (wt/wt). It is preferable that the above-described defatted green coffee beans are those obtained by extracting green coffee beans with N-hexane to thereby separate oily components therefrom. It is recommended to combine the above-described dietetic composition with one or more members selected from amongextract, evening primrose extract, sesamine and. This dietetic composition is usable as a material for foods, drinks, drugs, or skin preparations for external use.

Method for promoting carnitine palmitoyltransferase activity using green coffee bean extract

A membrane/electrode assemblyfor a polymer electrolyte fuel cell, which comprises an anodehaving an anode catalyst layercontaining an anode catalyst and an ion-exchange resin, a cathodehaving a cathode catalyst layercontaining a cathode catalyst and an ion-exchange resin, and a polymer electrolyte membranedisposed between the anodeand the cathode, wherein the anode catalyst is one having platinum or a platinum alloy supported on a carbon, and the amount of platinum or a platinum alloy supported in the anode catalyst is from 1 to 25 mass %; and the anode catalyst layercontains fine particles made of at least one member selected from iridium oxide, iridium, ruthenium oxide and ruthenium, and the fine particles have a specific surface area of from 2 to 50 m/g.

Membrane/electrode assembly for polymer electrolyte fuel cell and process for producing membrane/electrode assembly for polymer electrolyte fuel cell

Growing community of inventors

Tokyo, Japan

Hiroshi Shimoda